Tc Biopharm Plc Stock Price Prediction
| TCBPW Stock | USD 0.02 0.0005 3.03% |
Oversold Vs Overbought
42
Oversold | Overbought |
Quarterly Earnings Growth (0.87) |
Using TC BioPharm hype-based prediction, you can estimate the value of TC BioPharm plc from the perspective of TC BioPharm response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in TC BioPharm to buy its stock at a price that has no basis in reality. In that case, they are not buying TCBPW because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
TC BioPharm after-hype prediction price | USD 0.02 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
TCBPW |
TC BioPharm After-Hype Price Prediction Density Analysis
As far as predicting the price of TC BioPharm at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in TC BioPharm or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of TC BioPharm, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
TC BioPharm Estimiated After-Hype Price Volatility
In the context of predicting TC BioPharm's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on TC BioPharm's historical news coverage. TC BioPharm's after-hype downside and upside margins for the prediction period are 0.00 and 27.41, respectively. We have considered TC BioPharm's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
TC BioPharm is out of control at this time. Analysis and calculation of next after-hype price of TC BioPharm plc is based on 3 months time horizon.
TC BioPharm Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as TC BioPharm is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading TC BioPharm backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with TC BioPharm, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
3.31 | 27.37 | 0.00 | 0.06 | 2 Events / Month | 3 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.02 | 0.02 | 25.00 |
|
TC BioPharm Hype Timeline
TC BioPharm plc is at this time traded for 0.02. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.06. TCBPW is projected to increase in value after the next headline, with the price projected to jump to 0.02 or above. The average volatility of media hype impact on the company the price is over 100%. The price increase on the next news is projected to be 25.0%, whereas the daily expected return is at this time at 3.31%. The volatility of related hype on TC BioPharm is about 152055.56%, with the expected price after the next announcement by competition of 0.08. TC BioPharm plc has accumulated 1.8 M in total debt. TC BioPharm plc has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about TC BioPharm's use of debt, we should always consider it together with its cash and equity.Assuming the 90 days horizon the next projected press release will be in a few days. Check out TC BioPharm Basic Forecasting Models to cross-verify your projections.TC BioPharm Related Hype Analysis
Having access to credible news sources related to TC BioPharm's direct competition is more important than ever and may enhance your ability to predict TC BioPharm's future price movements. Getting to know how TC BioPharm's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how TC BioPharm may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ELYM | Eliem Therapeutics | 0.25 | 4 per month | 0.00 | (0.19) | 6.21 | (9.35) | 34.87 | |
| SCPH | Scpharmaceuticals | (0.1) | 7 per month | 0.00 | (0.21) | 4.05 | (7.09) | 20.70 | |
| MIST | Milestone Pharmaceuticals | 0.05 | 7 per month | 1.61 | 0.09 | 7.19 | (2.11) | 18.66 | |
| MCRB | Seres Therapeutics | (0.06) | 9 per month | 5.66 | 0.02 | 10.84 | (9.78) | 28.84 | |
| LUMO | Lumos Pharma | (0.05) | 6 per month | 2.72 | 0.05 | 5.95 | (5.19) | 16.25 |
TC BioPharm Additional Predictive Modules
Most predictive techniques to examine TCBPW price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for TCBPW using various technical indicators. When you analyze TCBPW charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About TC BioPharm Predictive Indicators
The successful prediction of TC BioPharm stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as TC BioPharm plc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of TC BioPharm based on analysis of TC BioPharm hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to TC BioPharm's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to TC BioPharm's related companies. | 2023 | 2024 (projected) | Graham Number | 611.53 | 580.95 | Receivables Turnover | 28.62 | 25.44 |
Story Coverage note for TC BioPharm
The number of cover stories for TC BioPharm depends on current market conditions and TC BioPharm's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that TC BioPharm is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about TC BioPharm's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
TC BioPharm Short Properties
TC BioPharm's future price predictability will typically decrease when TC BioPharm's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of TC BioPharm plc often depends not only on the future outlook of the potential TC BioPharm's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. TC BioPharm's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 30.9 K | |
| Cash And Short Term Investments | 2.5 M | |
| Shares Float | 98.4 M |
Additional Tools for TCBPW Stock Analysis
When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.